Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC
- 5 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 58 (5) , 433-444
Abstract
During the oxidative (10% H2O2) degradation of suvorexant drug substance, around 1.0% of one impurity and less than 1.0% four impurities were found by a new high-performance liquid chromatography (HPLC) assay and related substance method. The mass numbers of 1.0% impurity was 469 [M + H]+, remaining four impurities were 172 [M + H]+, 467 [M + H]+, 483 [M + H]+ and 485 [M + H]+. The 469 [M + H]+, 485[M + H] and 172 [M + H]+ impurities were characterized by using the LC-MS/MS, HR-MS and 1D, 2D NMR spectroscopic data. The 172 [M + H]+ impurity was prepared synthetically and co-injected in HPLC. The retention time of synthesized 172 [M + H]+ impurity was matching with the unknown degradation impurity in HPLC. The developed mass compatible HPLC and ultra performance liquid chromatography methods were validated for drug substance and process impurities by following ICH Q2 (R1) guidelines.Keywords
This publication has 24 references indexed in Scilit:
- Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodiumJournal of Pharmaceutical and Biomedical Analysis, 2008
- Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile studyJournal of Pharmaceutical and Biomedical Analysis, 2008
- Structural identification and characterization of potential impurities of pantoprazole sodiumJournal of Pharmaceutical and Biomedical Analysis, 2007
- Identification and characterization of potential impurities of rabeprazole sodiumJournal of Pharmaceutical and Biomedical Analysis, 2007
- Structural studies of impurities of risperidone by hyphenated techniquesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Identification and characterization of potential impurities of amlodipine maleateJournal of Pharmaceutical and Biomedical Analysis, 2006
- Isolation and characterization of impurities in docetaxelJournal of Pharmaceutical and Biomedical Analysis, 2006
- Identification and characterization of potential impurities of donepezilJournal of Pharmaceutical and Biomedical Analysis, 2004
- Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitorJournal of Pharmaceutical and Biomedical Analysis, 2004
- Impurity profile study of loratadineJournal of Pharmaceutical and Biomedical Analysis, 2003